Gevo, Inc. (NASDAQ:GEVO - Get Free Report) insider Lindsay Clinton Fitzgerald sold 8,987 shares of Gevo stock in a transaction dated Tuesday, June 3rd. The stock was sold at an average price of $1.16, for a total transaction of $10,424.92. Following the completion of the sale, the insider now owns 161,469 shares of the company's stock, valued at $187,304.04. This trade represents a 5.27% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Gevo Price Performance
Shares of NASDAQ:GEVO traded up $0.05 during midday trading on Friday, hitting $1.16. The stock had a trading volume of 3,020,160 shares, compared to its average volume of 5,435,664. The company's 50-day moving average price is $1.13 and its 200-day moving average price is $1.48. The company has a market capitalization of $277.89 million, a P/E ratio of -3.41 and a beta of 2.53. The company has a quick ratio of 8.05, a current ratio of 8.25 and a debt-to-equity ratio of 0.13. Gevo, Inc. has a fifty-two week low of $0.48 and a fifty-two week high of $3.39.
Gevo (NASDAQ:GEVO - Get Free Report) last issued its earnings results on Tuesday, May 13th. The energy company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.01. The company had revenue of $29.11 million during the quarter, compared to analysts' expectations of $22.19 million. Gevo had a negative net margin of 510.04% and a negative return on equity of 14.95%. As a group, equities research analysts predict that Gevo, Inc. will post -0.42 EPS for the current fiscal year.
Wall Street Analyst Weigh In
Several analysts have weighed in on GEVO shares. HC Wainwright reiterated a "buy" rating and issued a $14.00 price objective on shares of Gevo in a research note on Friday, May 30th. UBS Group dropped their price objective on shares of Gevo from $3.25 to $1.15 and set a "neutral" rating for the company in a research note on Wednesday, April 2nd.
Check Out Our Latest Research Report on GEVO
Hedge Funds Weigh In On Gevo
Several hedge funds and other institutional investors have recently made changes to their positions in GEVO. Raymond James Financial Inc. acquired a new position in shares of Gevo in the 4th quarter valued at approximately $27,000. IHT Wealth Management LLC acquired a new position in shares of Gevo in the 4th quarter valued at approximately $29,000. Y Intercept Hong Kong Ltd bought a new stake in shares of Gevo during the 1st quarter valued at approximately $36,000. Deutsche Bank AG grew its holdings in shares of Gevo by 5,808.4% during the 1st quarter. Deutsche Bank AG now owns 40,709 shares of the energy company's stock valued at $47,000 after purchasing an additional 40,020 shares during the last quarter. Finally, ExodusPoint Capital Management LP bought a new stake in shares of Gevo during the 4th quarter valued at approximately $49,000. 35.17% of the stock is currently owned by institutional investors and hedge funds.
About Gevo
(
Get Free Report)
Gevo, Inc operates as a carbon abatement company. It operates through three segments: Gevo, Agri-Energy, and Renewable Natural Gas. The company focuses on transforming renewable energy into energy-dense liquid hydrocarbons that can be used as renewable fuels. It offers renewable gasoline and diesel, isobutanol, sustainable aviation fuel, renewable natural gas, isobutylene, ethanol, and animal feed and protein.
See Also

Before you consider Gevo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Gevo wasn't on the list.
While Gevo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.